Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Isabel Leroux-Roels

Awards & Distinctions

Results : ALL ( 11 )

As Administrative supervisor

20 January 2022 → 07 November 2023

Harmonization of cellular immunoassays for the evaluation of influenza vaccine immunogenicity

Doctoral researcher: Gwenn Waerlop

16 November 2023 → 20 September 2026

Vaccine-induced immune response in transgender persons, differences with cisgender persons and impact of gender-affirming hormone therapy and/or sex chromosomes .

Doctoral researcher: Anthony Willems

As Promotor

01 January 2019 → 31 December 2023

Development of a vaccine against Rift Valley fever virus

Funding: Funding by bilateral agreement (private and foundations)

01 April 2020 → 31 March 2026

Effective and Affordable Flu Vaccines for the World

Funding: European funding: framework programme

01 July 2023 → 30 June 2028

Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines

Funding: European funding: framework programme

01 November 2025 → 31 October 2029

Investigating gender and sex differences in immune responses through vaccination of transgender persons

Fellow: Anthony Willems

Funding: Research Foundation - Flanders (FWO)

01 January 2025 → 31 December 2026

Investigating gender and sex differences in immune responses through vaccination of transgender persons

Funding: Regional and community funding: Special Research Fund

01 January 2024 → 31 December 2024

Investigating gender and sex differences in immune responses through vaccination of transgender persons

Funding: Regional and community funding: Special Research Fund

01 April 2021 → 31 March 2023

Rapid ex-vivo detection, quantification and characterisation of cell-mediated immune responses induced by natural infection or vaccination with SARS-CoV-2 orr other pathogens.

Funding: Regional and community funding: Industrial Research Fund

01 December 2025 → 30 November 2027

Systems vaccinology to elucidate molecular mechanisms of vaccine induced immune responses and protective immunity

Funding: Regional and community funding: Special Research Fund

As Copromotor

15 December 2022 → 14 December 2024

High-throughput, high-sensitivity and cost-effective monitoring of innate and adaptive immune responses at single cell level

Funding: Regional and community funding: Special Research Fund